JPRN-UMIN000006458已完成2 期
A Phase II study of capecitabine plus cisplatin (plustrastuzumab) for previously untreated advanced gastric cancer. - A Phase II study of capecitabine plus cisplatin (plustrastuzumab) for previously untreated advanced gastric cancer.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Severe hypersensitivity to have a history fluorouracil,platinum,trastuzumab 2)Senere renal failure 3)Within seven days stop S-1(tegaful gimerasil oterasil)treatment 4)Intend to make pregnant 5)Others
研究者
相似试验
已完成
2 期
A Phase II study of capecitabine plus cisplatin (plus trastuzumab) for previously untreated advanced gastric cancer.untreated advanced gastric cancerJPRN-UMIN000005998Department of Digestive surgery, Kawasaki Medical University53
已完成
2 期
PhaseII trial of capecitabine plus cisplatin in patients with recurrent HER-2 negative gastric cancer during or after the adjuvant chemotherapy using S-1 (T-CORE1102)HER2 negative gastric cancerJPRN-UMIN000006804Tohoku Clinical Oncoogy, Research and Education Society(T-CORE)21
招募中
2 期
A PhaseII study of XP(capecitabine plus cisplatin) combination therapy for HER2 negative advanced/recurrent gastric cancerHER2 negative advanced/recurrent gastric cancerJPRN-UMIN000013669SGCSG:Shimane Gstroenterological Vancer Study Group36
已完成
2 期
A Phase II Study of Capecitabine plus Paclitaxel Combination Chemotherapy in Patients with Metastatic Breast CancerMetastatic Breast CancerJPRN-UMIN000000869KBCSG (Kinki Breast Cancer Study Group)42
已完成
不适用
A phase II study of capecitabin plus oxaliplatin therapy (XELOX) for inoperable/advanced gastric cancer resistant/intolerable to fluoro-pyrimidine, CDDP, Taxane or CPT-11 (OGSG1403)unresectable/advanced gastric cancerJPRN-UMIN000016256Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)12